Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$36.48 - $52.22 $1,641 - $2,349
-45 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $16.5 Million - $27.5 Million
-499,773 Reduced 99.99%
45 $2,000
Q3 2021

Nov 10, 2021

SELL
$50.07 - $66.05 $241,287 - $318,294
-4,819 Reduced 0.95%
499,818 $25 Million
Q2 2021

Aug 10, 2021

BUY
$56.61 - $80.46 $237,422 - $337,449
4,194 Added 0.84%
504,637 $31.8 Million
Q1 2021

May 11, 2021

SELL
$86.23 - $125.19 $11.1 Million - $16.1 Million
-128,738 Reduced 20.46%
500,443 $46.5 Million
Q4 2020

Feb 05, 2021

BUY
$79.17 - $111.47 $13.2 Million - $18.5 Million
166,325 Added 35.93%
629,181 $56.4 Million
Q3 2020

Nov 10, 2020

BUY
$81.91 - $134.94 $8.32 Million - $13.7 Million
101,583 Added 28.12%
462,856 $47.8 Million
Q2 2020

Aug 06, 2020

BUY
$54.33 - $89.52 $19.4 Million - $32 Million
357,519 Added 9523.68%
361,273 $28.6 Million
Q1 2020

May 11, 2020

SELL
$49.34 - $68.76 $126,803 - $176,713
-2,570 Reduced 40.64%
3,754 $217,000
Q4 2019

Feb 10, 2020

SELL
$51.21 - $59.06 $19,459 - $22,442
-380 Reduced 5.67%
6,324 $341,000
Q3 2019

Nov 05, 2019

BUY
$40.6 - $57.2 $406 - $572
10 Added 0.15%
6,704 $350,000
Q2 2019

Aug 06, 2019

SELL
$39.92 - $53.86 $598 - $807
-15 Reduced 0.22%
6,694 $323,000
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $434 - $595
9 Added 0.13%
6,709 $339,000
Q4 2018

Feb 07, 2019

BUY
$55.63 - $73.24 $2,670 - $3,515
48 Added 0.72%
6,700 $397,000
Q3 2018

Nov 06, 2018

BUY
$52.05 - $66.51 $6,870 - $8,779
132 Added 2.02%
6,652 $438,000
Q2 2018

Aug 07, 2018

BUY
$48.33 - $55.64 $21,990 - $25,316
455 Added 7.5%
6,520 $329,000
Q1 2018

May 08, 2018

BUY
$44.44 - $54.39 $77,992 - $95,454
1,755 Added 40.72%
6,065 $319,000
Q4 2017

Jan 19, 2018

BUY
$37.77 - $47.75 $162,788 - $205,802
4,310
4,310 $200,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.